Metabotropic Glutamate Receptor-5 (mGlur5) Effects on Reward-Related fMRI-BOLD Activation in FHP and FHN

Trial Profile

Metabotropic Glutamate Receptor-5 (mGlur5) Effects on Reward-Related fMRI-BOLD Activation in FHP and FHN

Not yet recruiting
Phase of Trial: Phase 0

Latest Information Update: 11 Jan 2018

At a glance

  • Drugs Mavoglurant (Primary)
  • Indications Alcoholism
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 Jan 2018 Planned initiation date changed from 30 Nov 2017 to 17 Jan 2018.
    • 17 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top